Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

Excellence Unveiled: Karsen Kitchen
In the sixth installment of Excellence Unveiled, listen to Karsen Kitchen, class of 2025, discuss her 20-minute journey aboard a Blue Origin rocket and her...
Sat Jul 12, 2025

Coker Arboretum provides tranquility, history
At the intersection of East Cameron Avenue and Raleigh Street lies the Coker Arboretum, a lush green escape from the rest of UNC’s bustling campus...
Thu Jul 10, 2025

UNC ranked No. 3 best value public university by Princeton Review
UNC-Chapel Hill is ranked the No. 3 best value public university in the nation in The Princeton Review’s list of Best Value Colleges for 2025,...
Wed Jul 9, 2025

Orange County Hit Hard by Tropical Storm Chantal
More than 10 inches of rain fell in a matter of hours and rivers and creeks surged. In Chapel Hill, Morgan Creek exceeded flood stage...
Tue Jul 8, 2025